{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:48:21Z","timestamp":1763059701678,"version":"3.45.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Shock is a life-threatening clinical condition characterized by high morbidity and mortality. Drug-induced shock represents a complex subset of adverse drug reactions that has not been systematically investigated on a large scale. Comprehensive pharmacovigilance analyses are needed to identify high-risk drugs and drug combinations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted a retrospective pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS) covering the period from 2004Q1 to 2024Q2. Shock-related events were extracted using standardized MedDRA preferred terms. Data deduplication followed FDA guidelines, and four complementary signal detection methods\u2014reporting odds ratio (ROR), proportional reporting ratio (PRR), information component (IC), and empirical Bayes geometric mean (EBGM)\u2014were applied. Drug classification was performed using the Anatomical Therapeutic Chemical (ATC) system, and drug\u2013drug interaction analysis was carried out with the \u03a9 shrinkage method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>The initial dataset contained 3,611,216 duplicate records, and after deduplication, 17,947,720 demographic records were retained. From these, 8,511,840 records reported by healthcare professionals were included, yielding 277,956 shock-related adverse event reports involving 244,030 patients. Among these patients, 46.38% were female, 43.09% were male, and 10.53% had unspecified gender, while the main age groups were 45\u201364 years (27.35%) and \u226565 years (27.82%). Geographically, the United States accounted for 26.09% of reports, followed by France (8.20%), Japan (4.76%), and the United Kingdom (4.16%), with 99.26% of cases classified as serious events. Signal detection analysis showed that among 847 drugs, 158 (18.7%) were positive in three methods and 79 (9.3%) were positive in all four methods. Metformin was associated with 2,604,602 reports and amlodipine with 2,783,836 reports, both strongly linked to shock. ATC classification revealed cardiovascular drugs accounted for 32% of signals, anti-infectives for 28%, and nervous system drugs for 23%. High-risk drug combinations included anastrozole\u2009+\u2009levofloxacin (\u03a9\u2009=\u20094.23), duloxetine\u2009+\u2009ondansetron (\u03a9\u2009=\u20094.29), amphotericin B\u2009+\u2009fluoxetine (\u03a9\u2009=\u20094.30), quetiapine\u2009+\u2009sertindole (\u03a9\u2009=\u20094.25), and risperidone\u2009+\u2009sulfamethoxazole\/trimethoprim (\u03a9\u2009=\u20094.16). Performance evaluation showed the combined four-method approach achieved a positive predictive value of 94% and a negative predictive value of 89%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates strong associations between specific drug classes and shock, with cardiovascular, anti-infective, and nervous system agents identified as the most critical categories. The application of advanced multi-method signal detection enhances the accuracy of pharmacovigilance, reveals novel associations, and provides important evidence for clinical monitoring and risk management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0334785","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:42:11Z","timestamp":1763059331000},"page":"e0334785","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mining and analysis of drug-induced shock adverse reactions: A comprehensive pharmacovigilance study based on the US FAERS database"],"prefix":"10.1371","volume":"20","author":[{"given":"Junhua","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YiPing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JunTao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8019-4796","authenticated-orcid":true,"given":"ZhanHong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"pone.0334785.ref001","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"RS Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"pone.0334785.ref002","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"M Singer","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"pone.0334785.ref003","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00134-014-3525-z","article-title":"Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine","volume":"40","author":"M Cecconi","year":"2014","journal-title":"Intensive Care Med"},{"issue":"4","key":"pone.0334785.ref004","first-page":"401","article-title":"Epidemiology and causes of cardiogenic shock","volume":"27","author":"DD Berg","year":"2021","journal-title":"Curr Opin Crit Care"},{"issue":"7","key":"pone.0334785.ref005","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.872","article-title":"Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"19","author":"V-P Harjola","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"pone.0334785.ref006","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/medicina57090920","article-title":"Proadrenomedullin in Sepsis and Septic Shock: A Role in the Emergency Department","volume":"57","author":"A Piccioni","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"pone.0334785.ref007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0038-1676634","article-title":"Epidemiology of Pediatric Septic Shock","volume":"8","author":"DC de Souza","year":"2019","journal-title":"J Pediatr Intensive Care"},{"issue":"11","key":"pone.0334785.ref008","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/jcm8111838","article-title":"Back to Basics: Recognition of Sepsis with New Definition","volume":"8","author":"J Horak","year":"2019","journal-title":"J Clin Med"},{"issue":"9","key":"pone.0334785.ref009","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/toxins4090718","article-title":"Intranasal rapamycin rescues mice from staphylococcal enterotoxin B-induced shock","volume":"4","author":"T Krakauer","year":"2012","journal-title":"Toxins (Basel)"},{"issue":"1","key":"pone.0334785.ref010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13054-018-2102-1","article-title":"Definitions and pathophysiology of vasoplegic shock","volume":"22","author":"S Lambden","year":"2018","journal-title":"Crit Care"},{"issue":"13","key":"pone.0334785.ref011","doi-asserted-by":"crossref","first-page":"10772","DOI":"10.3390\/ijms241310772","article-title":"Successful Use of Methylene Blue in Catecholamine-Resistant Septic Shock: A Case Report and Short Literature Review","volume":"24","author":"MP Pluta","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0334785.ref012","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.annemergmed.2014.09.015","article-title":"Efficacy of methylene blue in an experimental model of calcium channel blocker-induced shock","volume":"65","author":"DH Jang","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"1","key":"pone.0334785.ref013","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/2168479013514236","article-title":"A Review of Statistical Methods for Safety Surveillance","volume":"48","author":"L Huang","year":"2014","journal-title":"Ther Innov Regul Sci"},{"issue":"1","key":"pone.0334785.ref014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pst.1652","article-title":"Evaluation of statistical methods for safety signal detection: a simulation study","volume":"14","author":"M Chen","year":"2015","journal-title":"Pharm Stat"},{"issue":"1","key":"pone.0334785.ref015","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41598-018-19979-7","article-title":"An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence","volume":"8","author":"C Xiao","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"pone.0334785.ref016","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40264-020-00911-w","article-title":"Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations","volume":"43","author":"O Caster","year":"2020","journal-title":"Drug Saf"},{"key":"pone.0334785.ref017","doi-asserted-by":"crossref","first-page":"1365706","DOI":"10.3389\/fphar.2024.1365706","article-title":"Clinical adverse events to dexmedetomidine: a real-world drug safety study based on the FAERS database","volume":"15","author":"F Liu","year":"2024","journal-title":"Front Pharmacol"},{"issue":"7","key":"pone.0334785.ref018","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA Adverse Event Reporting System","volume":"10","author":"T Sakaeda","year":"2013","journal-title":"Int J Med Sci"},{"issue":"11","key":"pone.0334785.ref019","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/cid\/cis664","article-title":"Fluoroquinolones and the risk of serious arrhythmia: a population-based study","volume":"55","author":"F Lapi","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pone.0334785.ref020","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0149-2918(00)80053-3","article-title":"The safety profile of the fluoroquinolones","volume":"22","author":"J Bertino","year":"2000","journal-title":"Clin Ther"},{"issue":"3","key":"pone.0334785.ref021","article-title":"Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India","volume":"14","author":"RK Tripathi","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"pone.0334785.ref022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jcpt.12357","article-title":"Quetiapine safety in older adults: a systematic literature review","volume":"41","author":"N El-Saifi","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"pone.0334785.ref023","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/02698811221104055","article-title":"Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019","volume":"36","author":"S Oh","year":"2022","journal-title":"J Psychopharmacol"},{"key":"pone.0334785.ref024","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.12688\/f1000research.21402.1","article-title":"Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications","volume":"8","author":"M Alomar","year":"2019","journal-title":"F1000Res"},{"issue":"1","key":"pone.0334785.ref025","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/0081175015570097","article-title":"Shrinkage Estimation of Log-odds Ratios for Comparing Mobility Tables","volume":"45","author":"X Zhou","year":"2015","journal-title":"Sociological Methodology"},{"issue":"7","key":"pone.0334785.ref026","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1553-2712.2012.01397.x","article-title":"Incidence of adverse cardiovascular events in adults following drug overdose","volume":"19","author":"AF Manini","year":"2012","journal-title":"Acad Emerg Med"},{"issue":"44","key":"pone.0334785.ref027","article-title":"Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis","volume":"96","author":"X Liu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"pone.0334785.ref028","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/s12879-023-08618-w","article-title":"Diagnosis and treatment of \u201cchronic Lyme\u201d: primum non nocere","volume":"23","author":"P S\u00e9bastien","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"2","key":"pone.0334785.ref029","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1021\/acsomega.8b03428","article-title":"Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase II\u03b1 and II\u03b2","volume":"4","author":"CA Fief","year":"2019","journal-title":"ACS Omega"},{"issue":"1","key":"pone.0334785.ref030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1541-0420.2009.01262.x","article-title":"False discovery rate estimation for frequentist pharmacovigilance signal detection methods","volume":"66","author":"I Ahmed","year":"2010","journal-title":"Biometrics"},{"issue":"10","key":"pone.0334785.ref031","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s40264-014-0218-z","article-title":"Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art","volume":"37","author":"R Harpaz","year":"2014","journal-title":"Drug Saf"},{"issue":"6","key":"pone.0334785.ref032","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/clpt.2013.47","article-title":"Pharmacovigilance using clinical notes","volume":"93","author":"P LePendu","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"pone.0334785.ref033","doi-asserted-by":"crossref","first-page":"1323057","DOI":"10.3389\/fdsfr.2023.1323057","article-title":"Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems","volume":"3","author":"PM Cutroneo","year":"2024","journal-title":"Front Drug Saf Regul"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:42:19Z","timestamp":1763059339000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334785"}},"subtitle":[],"editor":[{"given":"Yaser Mohammed","family":"Al-Worafi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0334785","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}